Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as dexpantenol [Bepantol]
dexpantenol · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | ACTIVE_COMPARATOR | - |
| 3 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Corticosteroids | DRUG | As prescribed |
| Placebo | DRUG | As prescribed |
| capecitabine [Xeloda] | DRUG | As prescribed |
| dexpantenol [Bepantol] | DRUG | As prescribed |
Inclusion Criteria: * adult patients, \>=18 years of age; * breast cancer or colorectal cancer patients; * treated with oral Xeloda for \<=5 days; * lack of hand-foot syndrome (palmar-plantar erythrodysesthesia). Exclusion Criteria: * existence of clinical symptoms suggesting hand-foot syndrome; ...
Top 20 of 91 competitors